Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immunodeficiencies (PID)”

86 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 86 results

Large-scale testing (Phase 3)Study completedNCT00751621
What this trial is testing

Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (EU Extension Study)

Who this might be right for
Primary Immunodeficiency (PID)
CSL Behring 40
Not applicableStudy completedNCT01859754
What this trial is testing

Octagam 5% Versus Comparator Post Marketing Trial

Who this might be right for
Primary Immune Deficiency Disorder
Octapharma 623
Post-approval studies (Phase 4)Study completedNCT03033745
What this trial is testing

Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra) in Subjects With Primary Immunodeficiency (PID)

Who this might be right for
Primary Immunodeficiency
CSL Behring 49
Testing effectiveness (Phase 2)Study completedNCT00782106
What this trial is testing

Study to Determine the Dose of Recombinant Human Hyaluronidase Needed to Infuse a Full Dose of IGIV Subcutaneously

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 11
Large-scale testing (Phase 3)Study completedNCT00538915
What this trial is testing

Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD)

Who this might be right for
Primary Immune Deficiency Disorders (PIDD)
ADMA Biologics, Inc. 63
Not applicableNot Yet RecruitingNCT07189013
What this trial is testing

Assessing Patient Preference for Infusion Systems

Who this might be right for
Primary Immunodeficiencies (PID)Secondary Immunodeficiencies (SID)
KORU Medical Systems, Inc. 52
Not applicableUnknownNCT03037359
What this trial is testing

A Study About Low Blood Pressure in Patients With Primary Immunodeficiency Disease Treated With Immune Globulin Products

Who this might be right for
Primary Immune Deficiency Disorder
ADMA Biologics, Inc. 200
Large-scale testing (Phase 3)Study completedNCT00168012
What this trial is testing

Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID)

Who this might be right for
AgammaglobulinemiaIgG DeficiencyCommon Variable Immunodeficiency
CSL Behring 42
Not applicableLooking for participantsNCT02735824
What this trial is testing

Genetic Study of Immunodeficiency: Search for New Genetic Causes for Primary Immunodeficiencies

Who this might be right for
Immunologic Deficiency SyndromesPrimary Immune Deficiency (PID)
University Children's Hospital, Zurich 500
Not applicableNot Yet RecruitingNCT06649643
What this trial is testing

Inbon Errors of Immunity Attending Assiut University Children&Amp;#39;s Hospital: a Single Center Study

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Assiut University 60
Large-scale testing (Phase 3)Study completedNCT04346108
What this trial is testing

Immune Globulin Subcutaneous (Human), 20% Solution (IGSC, 20%) in Japanese Participants With Primary Immunodeficiency Diseases (PID)

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 17
Not applicableUnknownNCT03148028
What this trial is testing

Immunological Characteristics of Patients With PID and IBD

Who this might be right for
Inflammatory Bowel DiseasesPrimary Immune Deficiency Disorder
Sheba Medical Center 45
Large-scale testing (Phase 3)Study completedNCT00419341
What this trial is testing

Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy

Who this might be right for
Primary Immune Deficiency
CSL Behring 49
Post-approval studies (Phase 4)UnknownNCT02490956
What this trial is testing

Diagnostic Immunization With Rabies Vaccine in Patients With PID

Who this might be right for
Primary Immunodeficiency
Chulalongkorn University 40
Not applicableStudy completedNCT02593188
What this trial is testing

Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 264
Not applicableUnknownNCT04572620
What this trial is testing

Rituximab and Abatacept Effectiveness in Differential Treatment of Interstitial Lymphocytic Lung Disease in Children With Primary Immunodeficiencies.

Who this might be right for
Interstitial Lymphocytic Lung Disease
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 30
Not applicableStudy completedNCT06150534
What this trial is testing

At-Home Subcutaneous Immunoglobulin Replacement Therapy Using Alexa Skill

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Takeda 22
Large-scale testing (Phase 3)Study completedNCT01218438
What this trial is testing

Phase 2/3 Study of IGSC, 20% in PIDD

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 86
Post-approval studies (Phase 4)Study completedNCT01289847
What this trial is testing

Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency

Who this might be right for
Primary Immune Deficiency DisordersCommon Variable ImmunodeficiencyX-linked Agammaglobulinemia+2 more
Bio Products Laboratory 25
Large-scale testing (Phase 3)Study completedNCT01458171
What this trial is testing

Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)

Who this might be right for
Primary Immune Deficiency Disorder
CSL Behring 23
Next Page